Detalhe da pesquisa
1.
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials.
Ann Oncol
; 34(1): 70-77, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209982
2.
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors.
Ann Oncol
; 31(10): 1405-1412, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622884
3.
Reply to letter to the editor "Bureaucracy or Streamlining the Rules in "Good Clinical Practice (GCP)" - Has Equipoise Occurred?" by H. K. Kotikonda, V. G. Jonnalagadda and S. R. Venna.
Ann Oncol
; 34(5): 498-499, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121610
4.
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).
Curr Oncol
; 25(1): e90-e94, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29507500
5.
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer.
Gastric Cancer
; 25(6): 1123-1124, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779127
6.
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Ann Oncol
; 27(12): 2268-2274, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733373
7.
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Ann Oncol
; 27(7): 1291-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117531
8.
Lymph node-only metastatic gastric/gastroesophageal junction cancer and efficacy of immunotherapy.
Gastric Cancer
; 23(6): 1107-1108, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424650
9.
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
Br J Cancer
; 107(7): 1025-30, 2012 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910320
10.
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies.
Ann Oncol
; 23(5): 1307-1313, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22015452
11.
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.
ESMO Open
; 7(6): 100633, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455504
12.
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.
ESMO Open
; 7(3): 100477, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653981
13.
Targeting BRAF for patients with melanoma.
Br J Cancer
; 104(3): 392-8, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139585
14.
Reporting incidental germline variants in the context of day-to-day somatic genomic profiling.
Ann Oncol
; 27(5): 758-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912559
15.
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma.
Crit Rev Oncol Hematol
; 157: 103173, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278677
16.
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study.
ESMO Open
; 6(4): 100200, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175675
17.
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.
Br J Cancer
; 103(3): 332-9, 2010 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20628389
18.
Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry.
Ann Oncol
; 21(1): 92-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19622595
19.
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
Br J Cancer
; 100(9): 1373-8, 2009 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19401696
20.
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.
Ann Oncol
; 20(1): 27-33, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18695026